First Citizens Bancshares Inc Class A logo

First Citizens Bancshares Inc Class A (FCNCA) Technical Analysis

$1,925.19-2.51%

Insights

  • First Citizens BancsharesClass A is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
  • Based on analysis of the Oscillators technical indicator, the current market trend for First Citizens BancsharesClass A stock suggests that it is range bound and no decision can be made based on this information
  • Based on analysis of the Moving Averages technical indicator, First Citizens BancsharesClass A stock is Range bound.
  • Based on analysis of the Pivot Points, the current market trend for First Citizens BancsharesClass A stock suggests that it is a good time to sell or bad time to initiate a fresh position

Analysis Summary

Oscillators

Sell

Neutral

Buy

Moving Averages

Sell

Neutral

Buy

Pivots

Sell

Neutral

Buy

Oscillators

Name

Value

Action

Relative Strength Index
52.02
Neutral
Stochastic
40.73, 33.19
Neutral
Ultimate Oscillator
50.23
Neutral
Stochastic Relative Strength Index
34.84, 26.51
Neutral
Moving Average Convergence Divergence
0.98, 0.72
Buy

Moving Averages

Simple Moving Average

Period (Days)

Value

Action

10
1967.14
Buy
20
1961.74
Sell
50
1995.98
Buy

Exponential Moving Average

Period (Days)

Value

Action

10
1963.83
Buy
20
1962.41
Buy
50
1956.85
Buy

Volume Weighted Moving Average

Period (Days)

Value

Action

10
1965.99
Neutral
20
1961.56
Neutral
50
1969.46
Neutral

Double Exponential Moving Average

Period (Days)

Value

Action

10
1964.52
Buy
20
1962.76
Sell
50
1983.21
Sell

Triple Exponential Moving Average

Period (Days)

Value

Action

10
1960.61
Sell
20
1967.46
Buy
50
1958.34
Sell

Pivot

Pivot

Value

Resistance L3
2014.26
Resistance L2
1993.8
Resistance L1
1979.12
Pivot Point
1958.66
Support L1
1943.97
Support L2
1923.51
Support L3
1908.83

*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.